The Regents of the University of California, San Francisco

Date of Award



Type 1 Diabetes: Prevent and Delay T1D



Term of Grant

48 months

Project Title

Rituximab Followed by Abatacept for Prevention or Reversal of Type 1 Diabetes (T1D)

The funds partially support a sequential combination trial to prevent or delay progression to clinical type 1 diabetes for those at high risk.